Pharmacokinetic Interactions Between Buprenorphine/Naloxone and Tipranavir/Ritonavir in HIV-Negative Subjects Chronically Receiving Buprenorphine/Naloxone

HIV-infected patients with opioid dependence often require opioid replacement therapy. Pharmacokinetic interactions between HIV therapy and opioid-dependence treatment medications can occur. HIV-seronegative subjects stabilized on at least 3 weeks of buprenorphine/naloxone (BUP/NLX) therapy sequenti...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Bruce, R. Douglas, Altice, Frederick L., Moody, David E., Lin, Shen-Nan, Fang, Wenfang B., Sabo, John P., Wruck, Jan M., Piliero, Peter J., Conner, Carolyn, Andrews, Laurie, Friedland, Gerald H.
Formato: Artigo
Idioma:Inglês
Publicado: 2009
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2779257/
https://ncbi.nlm.nih.gov/pubmed/19726139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2009.07.007
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares